Navigation Links
Intalere Teams with Ambry Genetics to Offer Healthcare Providers Advanced Genetic Testing for Cancer Risk Assessment
Date:4/9/2019

Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, today announced a new partnership with Ambry Genetics, a leading clinical genetic testing company. The collaboration will enable Intalere to offer its healthcare providers access to state-of-the-art clinical genetic testing and family history assessment, so they may better identify and manage patients with a high risk for cancer due to an inherited genetic mutation through the Ambry CARE (Comprehensive Assessment, Risk, and Education) Program.

“Numerous studies have shown that individuals at high risk for inherited cancer are not receiving necessary and timely clinical genetic testing,” said Tom Schoenherr, chief commercial officer of Ambry Genetics. “Ambry Genetics’ CARE program is a unique, end to end, customizable program that’s designed to help healthcare systems address this problem. Through CARE, we are able to assess populations of at-risk groups, provide risk values, genetic testing if needed, and then, through genetic counseling, educate patients on how their results may impact their current and future health.”

The benefits of Ambry Genetics' CARE program are aligned with the triple AIM of healthcare, in that they are designed to improve the patient experience, enhance the health of populations, and reduce the per capita cost of healthcare by identifying cancers early and reducing the long-term costs of patient care.

Specifically, the CARE Program will benefit providers and patients by:

  • Providing personalized cancer risk information
  • Making recommendations for increased screening based on national guidelines
  • Identifying family members who may also be at risk
  • Integrating seamlessly into existing workflows

Tom Schoenherr stressed that the CARE program is customizable. “We understand that health systems all have unique needs and requirements, so we provide a dedicated team of specialists who evaluate where and how to best implement these programs.”

Shon Wettstein, vice president of business development at Intalere, views the partnership with Ambry as an excellent fit. “We continually seek to partner with like-minded organizations that set the highest standards in their industry,” said Wettstein. “Ambry provides unmatched accuracy and specificity in their testing, offering patients and their families the most reliable and comprehensive information to proactively evaluate risk and identify any areas of concern.”

About Intalere
Intalere’s mission focuses on elevating the operational health of America’s healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers’ individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare’s nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit http://www.intalere.com to learn more.

About Ambry Genetics
Ambry Genetics is a leader in clinical diagnostic and software solutions, combining both to offer comprehensive and high-quality genetic testing. As part of the Konica Minolta family, Ambry Genetics is responsibly applying new technologies to the molecular diagnostics market to bring about precision medicine. With over 20 years of experience, Ambry Genetics has longstanding expertise in clinical genetic testing. For more information about Ambry Genetics,
visit http://www.ambrygen.com.

Read the full story at https://www.prweb.com/releases/intalere_teams_with_ambry_genetics_to_offer_healthcare_providers_advanced_genetic_testing_for_cancer_risk_assessment/prweb16227294.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. OHSU teams with Intel to decode the root causes of cancer and other complex diseases
2. NREL teams with Navy, private industry to make jet fuel from switchgrass
3. Home teams hold the advantage
4. Western University primatologist teams with international group to save lemurs
5. NXT-ID, Inc. Teams Up with StackCommerce to Sell Wocket Smart Wallet for Holiday Season
6. EyeLock Teams With Diebold to Bring Iris Identity Authentication to Banking Customers
7. VoiceIt Teams Up With VoicePass
8. Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting
9. Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer
10. Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management
11. Genetics Society of Americas GENETICS journal highlights for May 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 12, 2019 , ... With a rapidly growing customer ... the Geneious Biologics platform as a premium hub for bioinformatics and computer programming ... “The Geneious team has done an excellent job accommodating our specific data, resulting ...
(Date:6/6/2019)... ... 2019 , ... Ziegler, a specialty investment bank, is pleased ... (PBM) on its recent acquisition by PathGroup. , Headquartered in Lewisville (Dallas), ... than one dozen hospitals and surgery centers in the Dallas-Fort Worth and broader ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most ... features of seizure risk signals, usually based on variations of amplitude, frequency or ... only acceptable diagnostic methodology due to the complexity and variability of the signal, ...
Breaking Biology News(10 mins):
(Date:6/6/2019)... ... ... WCCT Global, Inc ., a full-service early phase contract research organization (CRO) ... 3 awards at the 2019 CRO Leadership Awards, to be held on June 24, ... Quality and Compatibility (Access to desired markets, cultural fit, timely project communications etc.) and ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, ... the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production ... and commercialization rights to a full spectrum of botulinum neurotoxins, as well as ...
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named William Charles Ballough ... the biomedical industry, where he is changing lives by creating solutions to global healthcare ... epitomizes the vision of our founders – Milton and Catherine Hershey – who always ...
(Date:5/8/2019)... ... , ... Standing at 16.2 hands, Atlas is on the large side for a Quarter Horse. ... racing, among other activities. When loping around a corner in late 2017, Atlas tripped ... horse to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the opinion ...
Breaking Biology Technology: